Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2CNS 2Sarcoma 1Other hematologic neoplasm 1Head & Neck 1Gastrointestinal 1Breast 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma, Follicular 1Cognition Disorders 1

Interventions

Rituximab 702Cyclophosphamide 643Vincristine 352Doxorubicin 307Etoposide 303Cytarabine 270Filgrastim 250Prednisone 248Methotrexate 240fludarabine phosphate 231Dexamethasone 208fludarabine 183Peripheral Blood Stem Cell Transplantation 165Radiotherapy 160Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 110Mycophenolic Acid 107Whole-Body Irradiation 106Tacrolimus 96Cyclosporine 86Gemcitabine 82Ifosfamide 80Alemtuzumab 80Calcium Dobesilate 79Leucovorin 77

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Transcranial Direct Current Stimulation × Lymphoid × Clear all
NCT06610617 2025-11-12

Neuromodulation of Central Sensory Integration to Improve Postural Control

University of Pittsburgh

Phase NA Completed
48 enrolled
Lymphoid

Cognition Disorders, Lymphoma, Follicular

NCT02336282 2023-09-18

Treatment for Executive Dysfunction in Adult Survivors of Childhood Acute Lymphoblastic Leukemia

St. Jude Children's Research Hospital

Phase NA Completed
53 enrolled 15 charts
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡